Home
About
Overview
Sharing Data
ORCID
Help
History (26)
Myeloid-specific deletion of Zfp36 protects against insulin resistance and fatty liver in diet-induced obese mice.
Prime Editing: A Novel Cas9-Reverse Transcriptase Fusion May Revolutionize Genome Editing.
Antkowiak, Peter
Guhn, Audrey
AAV-Mediated Gene Therapy for Glycosphingolipid Biosynthesis Deficiencies.
See All 26 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
AAV-Mediated Gene Therapy for Glycosphingolipid Biosynthesis Deficiencies.
Yang H, Brown RH, Wang D, Strauss KA, Gao G. AAV-Mediated Gene Therapy for Glycosphingolipid Biosynthesis Deficiencies. Trends Mol Med. 2021 06; 27(6):520-523.
View in:
PubMed
subject areas
Dependovirus
Epilepsy
Genetic Therapy
Genetic Vectors
Hereditary Sensory and Autonomic Neuropathies
Humans
Phenotype
Recombinant Proteins
Sialyltransferases
Spastic Paraplegia, Hereditary
authors with profiles
Dan Wang PhD
Kevin Strauss MD
Robert H Brown MD, DPhil
Guangping Gao PhD